For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

Inscripta, Inc.

USPTO Granted Patents = 166

CIPO Patents = 2

EPO Patents = 3

Trademarks = 9

Forward Citations = 1,877

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Phillip Belgrader (68 out of 122 patents)

Don Masquelier (68 out of 69 patents)

Andrew Garst (63 out of 78 patents)

4. Jorge Bernate (50 out of 50 patents)

5. Ryan T Gill (36 out of 68 patents)

6. Richard Fox (31 out of 31 patents)

7. Aamir Mir (25 out of 25 patents)

8. Benjamin Mijts (22 out of 22 patents)

9. Bruce Chabansky (22 out of 22 patents)

10. Kevin D Ness (22 out of 128 patents)

11. Juhan Kim (21 out of 21 patents)

12. Kyle Seamon (20 out of 20 patents)

13. Tian Tian (17 out of 17 patents)

14. Stephen Federowicz (17 out of 17 patents)

15. Michael Graige (16 out of 16 patents)

Core Competencies:

CRISPR-Cas9

Nucleic Acid-Guided Nucleases

Engineered Enzymes

Genome Editing

Automated Cell Processing

T-Cell Receptor Libraries

RNA Aptamers

Simultaneous Multiplex Editing

Detection of Edited Sequences

Nucleic Acid Landing Pads

Electroporation Modules

Viral Delivery Systems

166 patents: Sort by Forward Citations

1. 12416008 - Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers (2025-09-16),

2. 12195775 - Engineered enzymes and bioproduction of bakuchiol (2025-01-14),

3. 12195749 - Nucleic acid-guided nucleases (2025-01-14),

4. 12180502 - Nucleic acid-guided nucleases (2024-12-31),

5. 12146170 - Engineered enzyme (2024-11-19),

6. 11965186 - Nucleic acid-guided nickases (2024-04-23),

7. 11965154 - Detection of nuclease edited sequences in automated modules and instruments (2024-04-23),

8. 11891609 - Methods for increasing observed editing in bacteria (2024-02-06),

9. 11884924 - Dual strand nucleic acid-guided nickase editing (2024-01-30),

10. 11845932 - Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery (2023-12-19),

11. 11787841 - Rationally-designed mutations to the thrA gene for enhanced lysine production in (2023-10-17),

12. 11746347 - Simultaneous multiplex genome editing in yeast (2023-09-05),

13. 11739290 - Instruments, modules, and methods for improved detection of edited sequences in live cells (2023-08-29),

14. 11697826 - Nucleic acid-guided nucleases (2023-07-11),

15. 11685889 - Detection of nuclease edited sequences in automated modules and instruments (2023-06-27),

Inscripta is a gene-editing technology company that develops a revolutionary platform for precise and reliable gene editing. Their platform, called Onyx, combines proprietary CRISPR enzymes, synthetic biology, and high-throughput automation to enable researchers to engineer biological systems with unprecedented flexibility and precision.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

166 Patents

#3 in Boulder, CO

#42 in Colorado

#2,320 in US

#4,842 in the World

Boulder, CO, United States of America

Inscripta, Inc.

Forward Citations = 1,877

65 inventors:

Phillip Belgrader (68 out of 122 patents)

Don Masquelier (68 out of 69 patents)

Andrew Garst (63 out of 78 patents)

4. Jorge Bernate (50 out of 50 patents)

5. Ryan T Gill (36 out of 68 patents)

Please report any incorrect information to support@idiyas.com

Loading…